BIOMAT Database Logo BIOMAT Database Logo

Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. 1999

S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
Department of Biochemistry, Kanazawa University School of Medicine, Kanazawa, 920-8640, Japan.

Insulin treatment is known epidemiologically as an independent risk factor for the progression of diabetic retinopathy. However, how insulin exacerbates the retinopathy is not yet fully understood. In this study, we investigate the effects of insulin on the growth and tube formation of microvascular endothelial cells (EC). When human skin microvascular EC were grown under various concentrations of insulin, DNA synthesis as well as tube formation of EC was found to be significantly stimulated. We obtained evidence that it is mainly vascular endothelial growth factor (VEGF) that mediates the angiogenic activity of insulin as follows. (1) Insulin upregulates the level of mRNA coding for secretory forms of VEGF, while the expression of the two VEGF receptor genes, kinase insert domain-containing receptor (kdr) and fms-like tyrosine kinase1 (flt1), was essentially unchanged by exposure to insulin. (2) A monoclonal antibody against human VEGF can completely neutralize both the proliferation and the tube formation of EC induced by insulin. The angiogenic effects of insulin were additive with those of hypoxia, a principal factor that causes angiogenesis. Further, insulin significantly stimulated plasminogen activator inhibitor-1 activity in EC. The results thus suggest that insulin not only elicits angiogenesis through the induction of autocrine VEGF but also is a predisposing factor for thrombogenesis, which may give rise to focal ischemia that could superdrive angiogenesis, thereby leading to the exacerbation of diabetic retinopathy.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005314 Embryonic and Fetal Development Morphological and physiological development of EMBRYOS or FETUSES. Embryo and Fetal Development,Prenatal Programming,Programming, Prenatal

Related Publications

S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
An autocrine loop mediates expression of vascular endothelial growth factor in human dermal microvascular endothelial cells.
April 2001, The Journal of investigative dermatology,
S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
Endocrine gland-derived vascular endothelial growth factor stimulates proliferation and tube formation in human uterine microvascular endothelial cell through the mitogen-activated protein kinase but not through the Akt pathway.
May 2009, Fertility and sterility,
S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells.
February 1992, Atherosclerosis,
S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
Silence of lncRNA UCA1 Represses the Growth and Tube Formation of Human Microvascular Endothelial Cells Through miR-195.
January 2018, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism.
April 2006, Gastroenterology,
S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
Butyrate increases the formation of anti-angiogenic vascular endothelial growth factor variants in human lung microvascular endothelial cells.
December 2010, Molecular biology reports,
S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
Vascular endothelial growth factor stimulates osteoblastic differentiation of cultured human periosteal-derived cells expressing vascular endothelial growth factor receptors.
February 2011, Molecular biology reports,
S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
November 2008, Clinical cancer research : an official journal of the American Association for Cancer Research,
S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
Recombinant human erythropoietin stimulates vascular endothelial growth factor release by glomerular endothelial cells.
May 1999, European journal of pharmacology,
S Yamagishi, and T Kawakami, and H Fujimori, and H Yonekura, and N Tanaka, and Y Yamamoto, and H Urayama, and Y Watanabe, and H Yamamoto
Insulin-like growth factor I stimulates angiogenesis and the production of vascular endothelial growth factor.
April 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
Copied contents to your clipboard!